Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Asch

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Long Range Planning|March 9, 1992
Strategic control: a problem looking for a solutionD Asch
American Journal of Clinical Oncology|April 8, 2006
The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin diseaseMerideth M M Wendland, Julie D Asch, Michael A Pulsipher, et al.
American Journal of Clinical Oncology|April 7, 2007
The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplantMerideth M M Wendland, David C Smith, Kenneth M Boucher, et al.
British Journal of Haematology|July 25, 2022
Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemiaSrinivas K Tantravahi, Bryan D Huber, Jennie Vagher, et al.
Cancer|May 13, 2016
Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemiaAmir T Fathi, Daniel J DeAngelo, Kristen E Stevenson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Long Range Planning|March 9, 1992
Strategic control: a problem looking for a solutionD Asch
American Journal of Clinical Oncology|April 8, 2006
The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin diseaseMerideth M M Wendland, Julie D Asch, Michael A Pulsipher, et al.
American Journal of Clinical Oncology|April 7, 2007
The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplantMerideth M M Wendland, David C Smith, Kenneth M Boucher, et al.
British Journal of Haematology|July 25, 2022
Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemiaSrinivas K Tantravahi, Bryan D Huber, Jennie Vagher, et al.
Cancer|May 13, 2016
Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemiaAmir T Fathi, Daniel J DeAngelo, Kristen E Stevenson, et al.
Pageof 1